sábado, 4 de diciembre de 2021

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro - EBioMedicine

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro - EBioMedicine

No hay comentarios:

Publicar un comentario